|
|
|
|
|
|||||||
|
Session 83
Poster Session
Discontinuation of Prophylaxis/Risk of Opportunistic Infections 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 629-W. | Predictive Value of HIV-1 Viral Load on Risk for Opportunistic Infection: Adult AIDS Clinical Trial Group (AACTG) 722 S. Evans1, S. Swindells*2, H. Balfour3, and R. Zackin1 1Harvard Sch. of Publ. Health, Boston, MA; 2Univ. of Nebraska Med. Ctr., Omaha; and 3Univ. of Minnesota, Minneapolis
| ||
| 630-W. | Long-Term Follow-Up of HIV-Infected Individuals who have Experienced Immune Reconstitution Following Severe Immunosuppression S. L. Koletar*1, J. Wu2, J. A. McCutchan3, P. L. Williams2, R. L. Murphy4, T. Nevin5, and J. S. Currier6 for the ACTG 362 Team 1Ohio State Univ., Columbus; 2Harvard Sch. of Publ. Hlth., Boston, MA; 3Univ. of California, San Diego;4Northwestern Univ., Chicago, IL;5AACTG Operations Ctr., Rockville, MD; and 6Univ. of California, Los Angeles
| ||
| 631-W. | Continued Low Rates of Mycobacterium avium Complex (MAC) and Bacterial Pneumonia despite Withdrawal of Azithromycin Prophylaxis among Patients with CD4 Cell Rebound W. Burman *1, W. El-Sadr2, J. Matts3, R. Hafner4, L. Crane5, and F. Gordin6 1 Denver Publ. Hlth., CO; 2 Harlem Hosp. Ctr., New York, NY; 3 Univ. of Minnesota, Minneapolis; 4 NIAID, NIH, Bethesda, MD; 5 Wayne State Univ., Detroit, MI; and 6VA Med. Ctr., Washington, DC
| ||
| 632-W. | Toxoplasma gondii-Specific T-Cell Responses Are Restored in AIDS Patients who Discontinued Toxoplasma Encephalitis (TE) Secondary Prophylaxis (SP) after Immunological Reconstitution Due to Potent Antiretroviral Therapy (HAART) J. Miro*1, M. Leujeune1, X. Claramonte1, E. Martinez1, E. Ribera2, J. Arrizabalaga3, J. R. Arribas4, P. Domingo5, E. Ferrer6, M. Plana1, M. E. Valls1, D. Podzamczer6, T. Pumarola1, A. Jacquet7, J. Mallolas1, T. Gallart1, and J. M. Gatell1 1Hosp. Clin.-Idibaps, Univ. of Barcelona, Spain; 2 Hosp. Vall d“Hebron, Barcelona, Spain; 3 Hosp. Ntra. Sra. de Aranzazu, San Sebastian, Spain; 4 Hosp. La Paz, Madrid, Spain; 5 Hosp. Sant Pau, Barcelona, Spain; 6 Hosp. de Bellvitge, Barcelona, Spain; and 7 Univ. Libre de Bruxelles, Belgium
| ||
| 633-W. | Discontinuation of Maintenance Therapy against Toxoplasma Encephalitis may not be Safe despite Sustained Response to Antiretrviral Combination Therapy S. Bertschy1, M. Opravil2, A. Telenti3, E. Bernasconi5, V. Schiffer4, P. Vernazza6, M. Flepp2, J. P. Chave3, and H. Furrer*1 for the Swiss HIV Cohort Study Univ. Hosp., 1Berne; 2Zurich; 3Lausanne; 4Geneva; 5Cantonal Hosp., Lugano; and 6St.Gall, Switzerland
| ||
| 634-W. | ACTG 393: A Study of Discontinuing Maintenance Therapy in Subjects with Disseminated Mycobacterium avium Complex (DMAC) J. A. Aberg*1, P. L. Williams2, T. Liu2, H. M. Lederman3, C. Inderlied4, F. Torriani5, S. Owens6, T. Nevin7, and J. S. Currier8 1Washington Univ., St. Louis, MO; 2Harvard Univ., Boston, MA; 3Johns Hopkins Univ., Baltimore, MD; 4Univ. of Southern California, Los Angeles; 5Univ. of California, San Diego; 6FSTRF, Amherst, NY; 7ACTG OPS, Silver Spring, MD; and 8Univ. of California, Los Angeles
| ||
| 635-W. | Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients Treated with HAART: A Multicentre Observational Study C. Mussini*1, P. Pezzotti2, V. Borghi1, E. Martinez3, J. Mirņ3, J. Aberg4, P. Bossi5, A. Bedini1, P. Cinque6, A. M. Cattelan7, R. Manfredi8, L. M. Vaira9, A. Lazzarin6, A. Cossarizza10, R. Esposito1, and A. Antinori2 1Modena, Italy; 2Rome, Italy; 3Barcelona, Spain; 4Washington, DC; 5Paris, France; 6Milan, Italy; 7Padua, Italy; 8Bologna, Italy; 9Monza, Italy; and 10Modena , Italy
| ||
| 636-W. | HIV Patients on HAART: Why Are They Still Admitted to the Hospital? J. Pulvirenti*, P. Venkataraman, P. Shastri, J. Sarazine, C. Gail, and R. Glowacki Cook County Hosp., Rush Med. Coll., Univ. of Illinois Med. Ctr., Chicago
|
